Cancer is one of the most difficult diseases to fight. It is often best to simultaneously attack cancer cells using as many modalities as possible. In addition to the standard medical approach, many doctors and patients request our help to incorporate complimentary therapies.
These complimentary therapies do not interfere with traditional treatments, but can offer significant help in the battle against cancer. The following are several supplements and compounds most frequently requested by our cancer patients and their physicians.
Melatonin Capsules (high dose)
Melatonin is a hormone secreted by the pineal gland at nighttime to aid the body in falling asleep. It is commonly sold as an over the counter (OTC) dietary supplement in doasges ranging from 0.3 mg – 3 mg.
Research into Melatonin’s anti-cancer properties has steadily increased since the early 1990’s. Melatonin is toxic to many types of human tumor cells, and it has been shown to slow the growth rate of established tumors. High doses of Melatonin have also been shown to inhibit the tumor from forming new blood vessels, discouraging the spread of cancer throughout the body.
At Lee Silsby, we compound Melatonin Capsules at the higher dosages that have been studied and shown to improve survival time for those suffering from various types of cancers.
Beta-1, 3-D Glucan Capsules
Beta-1, 3-D Glucan is derived from the cell walls of baker's yeast (saccharomyces cerevisiae). Beta glucan is well known by immunologists for its immune enhancing properties. It works by fully activating macrophages in your body, one of the primary defenses of the immune system. Macrophages trap and consume foreign invaders such as bacteria, viruses, and parasites. Several studies have also shown macrophages to kill tumor cells.
It is important that only the highest quality Beta-1, 3-D Glucan is used for maximum effectiveness. Our compounded Beta-1, 3-D Glucan capsules utilize the purest form of Beta-1, 3-D Glucan that is available.
Additional compounds and supplements for the use in cancer patients are being developed and will be added in the future.